Ipamorelin, the first selective growth hormone secretagogue.
Researchers observed that ipamorelin is a selective growth hormone secretagogue with high potency for stimulating growth hormone release without affecting other hormone levels.
NNC 26-0161
Ipamorelin is a synthetic peptide classified as a growth hormone secretagogue, derived from the structure of ghrelin, a hormone that stimulates growth hormone release. Researchers primarily study ipamorelin for its potential role in enhancing muscle growth, improving body composition, and promoting tissue regeneration. Key findings from preclinical studies suggest that ipamorelin can increase bone mineral content and stimulate the signaling pathways associated with muscle repair and growth. Additionally, studies indicate that when combined with other peptides, such as CJC-1295, ipamorelin may enhance muscle recovery in animal models. Despite these promising results, current research is limited, with a notable lack of clinical trials in humans, highlighting the need for further investigation into its safety and efficacy.
| Formula | C38H49N9O5 |
| Molecular Weight | 711.9 g/mol |
| CAS Number | 170851-70-4 |
| PubChem CID | 9831659 |
~2 hours
Not applicable
Poor bioavailability
Ipamorelin's pharmacokinetics are characterized by a short half-life and limited oral bioavailability, necessitating injectable administration for effective use.
Ipamorelin acts as a selective growth hormone secretagogue by binding to the growth hormone secretagogue receptor (GHS-R), leading to the activation of the GH/IGF-1 signaling pathway. This interaction stimulates the release of growth hormone (GH) from the anterior pituitary, which subsequently activates the insulin-like growth factor 1 (IGF-1) signaling pathway, promoting processes such as tissue regeneration, muscle growth, and bone mineralization. While the precise molecular mechanisms remain to be fully elucidated, ipamorelin is known to influence pathways involved in cellular growth and metabolism, including the mTOR and PI3K/Akt pathways.
925
Total Citations
10
Human/RCT
2.1
Avg. Influence
2020
Latest
Researchers observed that ipamorelin is a selective growth hormone secretagogue with high potency for stimulating growth hormone release without affecting other hormone levels.
Researchers observed that a liquid chromatography-mass spectrometry method effectively detects growth hormone releasing peptides, including ipamorelin, in human urine for doping control.
The study demonstrated that ipamorelin increased body fat and weight in both GH-deficient and GH-intact mice, suggesting GH-independent mechanisms of action.
The study demonstrated that NN703, derived from ipamorelin, effectively stimulates growth hormone release in swine and dogs, exhibiting high potency and oral bioavailability.
The study demonstrated a validated screening assay for prohibited peptides, including ipamorelin, in urine, achieving high specificity and sensitivity for doping control.
Researchers observed that growth hormone expression in seabream is regulated by ipamorelin, with the ghrelin gene exhibiting tissue-specific promoter activity.
Researchers observed the identification of 28 metabolites from growth hormone releasing peptides, including ipamorelin, in urine samples from rats, which may aid in doping control analysis.
Researchers observed that ipamorelin and other GHRPs were metabolized and excreted in urine, with varying detection windows depending on individual metabolism and administration route.
Researchers observed successful detection of multiple growth hormone releasing peptides, including ipamorelin, in equine and human urine using a novel extraction and derivatization method.
Researchers observed that a novel class of growth hormone secretagogues derived from ipamorelin exhibited oral bioavailability and maintained in vivo potency in swine.
No randomized controlled human trials have been conducted specifically on ipamorelin and its effects on musculoskeletal injuries or athletic performance. Additionally, the long-term safety and efficacy of ipamorelin in various populations, particularly in hypogonadal males and athletes, remain largely unknown, as does the detailed mechanism of action in human subjects.
Solubility
Ipamorelin is soluble in water and DMSO.
Lyophilized
Stable for 2+ years at -20°C, 12 months at 4°C
Reconstituted
Use within 14 days when refrigerated at 4°C
Avoid
Avoid repeated freeze-thaw cycles, direct light
Solvent
Bacteriostatic water or sterile saline recommended
Safety information is derived from published research and may not reflect all known risks. This is not medical advice.
🇩🇪DE
Not approved as a medicinal product. Not a controlled substance. Sale as research chemical is a legal grey area.
🇺🇸US
Not approved by the FDA for clinical use. Not scheduled by the DEA.
🇦🇺AU
Not approved by the TGA for therapeutic use.
🇬🇧UK
Not approved by the MHRA for medicinal use.
Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.
Publications per Year
41 total| Vendor | Amount | Price | Price/mg | Link |
|---|---|---|---|---|
BESTGeo PeptidesUS | 10mg | $34.99 | $3.50/mg | |
Puratek PeptidesUS | 10mg | $37.95$34.16 | $3.80$3.42/mg | View−10% · PEPSTACKS10 |
Research Peptides UKUK | 5mg | $18.99 | $3.80/mg | |
Proto PeptideUS | 10mg | $40.00 | $4.00/mg | |
Step OneUS | 10mg | $40.00 | $4.00/mg |
Top 5 of 59 offers from 66 vendors. Prices updated daily.
See all Ipamorelin pricesLog your research cycles, set reminders and visualize serum levels.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer